Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease

Philip S Insel, Niklas Mattsson-Carlgren, Oliver Langford, Vincent M Caruso, Antoine Leuzy, Christina B Young, Adam Boxer, Paul S Aisen, Reisa A Sperling, Elizabeth C Mormino, Michael C Donohue

IMPORTANCE: Developing disease-modifying treatments is a priority for Alzheimer disease research.